Clinical Trial Update: A Study of LY3009120 in Participants With Advanced Cancer or Cancer That Has Spread to Other Parts of Their Body [Phase 1]

View source ↗

Summary

Phase 1 trial of LY3009120 in advanced/metastatic cancer was terminated; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma Non-small-cell Lung
• Colorectal Neoplasms
• Melanoma
• Neoplasm Metastasis
• Neoplasms

Drugs mentioned

• LY3009120

Snippet

Sponsor: Eli Lilly and Company | Conditions: Neoplasms, Neoplasm Metastasis | Phase 1 | Status: TERMINATED | Results posted: 2019-12-27